Covalent bonding drugs have been rising recently in drug discovery. With handfuls being approved in the past century for various ailments such as cancers and viruses. Using conversion of compounds and multi-step synthesis through the summer, and applying concepts learned from organic chemistry such as the hydrolysis of esters into acids, boc protection, amide bond formation, carbamate formation, and Wittig-Horner reactions we have been able to start with a diol and end with an amide. This amide will be paired with a library of acids in house to form structures which haven’t been sought after, and to be further screened in cells against enzymes. Ramifications that arose during this project were mostly due to reactions not working in time, ha...
Covalent drugs have been used to treat diseases for more than a century, but tools that facilitate t...
Biologically active natural products can be regarded as evolutionary selected and biologically valid...
Small-molecule libraries with enhanced structural diversity are of value in drug discovery campaigns...
The new technology of combinational chemistry has been introduced to pharmaceutical companies, impro...
The development of modern pharmaceuticals relies heavily upon the drug discovery process to uncover ...
Covalent bond-forming reactions between small molecules and proteins are ubiquitous. These reactions...
Resum de la ponència presentada al 1st Molecules Medicinal Chemistry Symposium. Barcelona, 8 septemb...
Development of novel therapeutics has been one of the most pivotal parts in medicinal chemistry, esp...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
The phenomenal potential of synthetic chemistry to influence small molecule therapeutic development ...
The phenomenal potential of synthetic chemistry to influence small molecule therapeutic development ...
The research reported in this thesis explored and developed the formation of reversible and irrevers...
UnrestrictedA very rare opportunity has been bestowed into me to work in three different facets of o...
Covalent drugs have been used to treat diseases for more than a century, but tools that facilitate t...
Biologically active natural products can be regarded as evolutionary selected and biologically valid...
Small-molecule libraries with enhanced structural diversity are of value in drug discovery campaigns...
The new technology of combinational chemistry has been introduced to pharmaceutical companies, impro...
The development of modern pharmaceuticals relies heavily upon the drug discovery process to uncover ...
Covalent bond-forming reactions between small molecules and proteins are ubiquitous. These reactions...
Resum de la ponència presentada al 1st Molecules Medicinal Chemistry Symposium. Barcelona, 8 septemb...
Development of novel therapeutics has been one of the most pivotal parts in medicinal chemistry, esp...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
International audienceNitrogen containing molecules are essential for life. They are also key produc...
The phenomenal potential of synthetic chemistry to influence small molecule therapeutic development ...
The phenomenal potential of synthetic chemistry to influence small molecule therapeutic development ...
The research reported in this thesis explored and developed the formation of reversible and irrevers...
UnrestrictedA very rare opportunity has been bestowed into me to work in three different facets of o...
Covalent drugs have been used to treat diseases for more than a century, but tools that facilitate t...
Biologically active natural products can be regarded as evolutionary selected and biologically valid...
Small-molecule libraries with enhanced structural diversity are of value in drug discovery campaigns...